Skip to main content
. 2017 Jun 13;7:3431. doi: 10.1038/s41598-017-03477-3

Figure 6.

Figure 6

OMS inhibits Mtb-induced inflammatory responses through AMPK activation. (a) BMDMs were infected with Mtb (moi = 10) for 4 h and then treated with OMS-A (1, 5, 10 μM) or OMS-B (1, 5, 10 μM) for 24 h. (b) BMDMs were transduced with adenoviral NF-ĸB-luciferase reporter plasmid for 36 h, and infected with Mtb and then treated with OMS-A or OMS-B for 6 h. The cells were harvested and NF-ĸB luciferase reporter activity was determined. (c) BMDMs were transduced with non-specific shRNA (shNS) or Ampk-specific shRNA (shAmpk)-expressing lentivirus for 48 h and then infected with Mtb, followed by treatment with OMS-A or OMS-B for 24 h. (a and c) The supernatants were harvested and subjected of ELISA analysis of TNF-α, IL-6, IL-1β, and IL-12p40 production. All data represent the means ± SD of triplicates from each sample. **p < 0.01, ***p < 0.001, compared with SC (ac). U, uninfected/untreated; SC, solvent control; ns, no significant.